Risk factors for incident osteoarthritis of the hip and knee.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 3261259)

Published in Curr Rev Musculoskelet Med on September 01, 2011

Authors

R Krishna Chaganti1, Nancy E Lane

Author Affiliations

1: Division of Rheumatology, University of California, San Francisco, USA, chaganti@medicine.ucsf.edu.

Articles cited by this

Radiological assessment of osteo-arthrosis. Ann Rheum Dis (1957) 42.98

Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12

The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38

The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA (2001) 7.15

Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis (1989) 6.52

Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol (2006) 6.03

An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum (1998) 5.72

High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury. Arthritis Rheum (2004) 5.72

Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum (2007) 4.97

Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum (2000) 4.52

Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum (2008) 4.50

Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum (1997) 4.08

The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93

Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum (1995) 3.89

Genetic influences on osteoarthritis in women: a twin study. BMJ (1996) 3.70

Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy. Arthritis Rheum (2004) 2.96

Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology (1999) 2.69

Occupational physical demands, knee bending, and knee osteoarthritis: results from the Framingham Study. J Rheumatol (1991) 2.56

Occupational physical activities and osteoarthritis of the knee. Arthritis Rheum (2000) 2.54

Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study. Arthritis Rheum (1998) 2.45

Risk of osteoarthritis associated with long-term weight-bearing sports: a radiologic survey of the hips and knees in female ex-athletes and population controls. Arthritis Rheum (1996) 2.14

Effect of recreational physical activities on the development of knee osteoarthritis in older adults of different weights: the Framingham Study. Arthritis Rheum (2007) 2.12

Knee alignment does not predict incident osteoarthritis: the Framingham osteoarthritis study. Arthritis Rheum (2007) 2.11

Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med (1998) 2.09

A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum (2010) 2.02

Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group. Arthritis Rheum (1999) 1.80

Early identification of radiographic osteoarthritis of the hip using an active shape model to quantify changes in bone morphometric features: can hip shape tell us anything about the progression of osteoarthritis? Arthritis Rheum (2007) 1.57

Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum (1996) 1.56

The effect of running on the pathogenesis of osteoarthritis of the hips and knees. Clin Orthop Relat Res (1985) 1.48

Running and primary osteoarthritis of the hip. Br Med J (1975) 1.46

Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1996) 1.42

The association of proximal femoral shape and incident radiographic hip OA in elderly women. Osteoarthritis Cartilage (2009) 1.41

Association of mild acetabular dysplasia with an increased risk of incident hip osteoarthritis in elderly white women: the study of osteoporotic fractures. Arthritis Rheum (2000) 1.36

Acetabular dysplasia predicts incident osteoarthritis of the hip: the Rotterdam study. Arthritis Rheum (2005) 1.33

Osteoarthritis of the hip and acetabular dysplasia. Ann Rheum Dis (1991) 1.31

High prevalence of lateral knee osteoarthritis in Beijing Chinese compared with Framingham Caucasian subjects. Arthritis Rheum (2002) 1.27

Obesity, physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis--a population-based study with a follow-up of 22 years. Rheumatology (Oxford) (2009) 1.25

Estrogen use and radiographic osteoarthritis of the knee in women. The Framingham Osteoarthritis Study. Arthritis Rheum (1990) 1.21

Osteoarthritis of the hip joint and acetabular dysplasia in women. Ann Rheum Dis (1995) 1.19

The risk of osteoarthritis with running and aging: a 5-year longitudinal study. J Rheumatol (1993) 1.15

Effect of hormone therapy on risk of hip and knee joint replacement in the Women's Health Initiative. Arthritis Rheum (2006) 1.09

Frequency of varus and valgus thrust and factors associated with thrust presence in persons with or at higher risk of developing knee osteoarthritis. Arthritis Rheum (2010) 1.02

Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr (2003) 0.99

Genetic indicators and susceptibility to osteoarthritis. Br J Sports Med (2011) 0.86

Is Running Associated with Osteoarthritis? An Eight-Year Follow-up Study. J Clin Rheumatol (1995) 0.84

Variation at the ANP32A gene is associated with risk of hip osteoarthritis in women. Arthritis Rheum (2009) 0.82

Articles by these authors

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med (2006) 10.95

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum (2008) 4.02

Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab (2006) 3.15

Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med (2012) 2.80

Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum (2009) 2.47

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum (2008) 2.37

A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum (2010) 2.02

Wntless functions in mature osteoblasts to regulate bone mass. Proc Natl Acad Sci U S A (2012) 1.85

Targeted deletion of Sost distal enhancer increases bone formation and bone mass. Proc Natl Acad Sci U S A (2012) 1.78

Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int (2008) 1.71

The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. Arthritis Rheum (2007) 1.65

Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. Ann Am Thorac Soc (2015) 1.54

The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J Bone Miner Res (2003) 1.52

Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis (2010) 1.51

Patellar cartilage: T2 values and morphologic abnormalities at 3.0-T MR imaging in relation to physical activity in asymptomatic subjects from the osteoarthritis initiative. Radiology (2009) 1.47

The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis. J Rheumatol (2002) 1.38

Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum (2008) 1.36

Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study. Arthritis Rheum (2002) 1.36

The effects of impaired joint position sense on the development and progression of pain and structural damage in knee osteoarthritis. Arthritis Rheum (2009) 1.33

Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum (2008) 1.33

Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res (2010) 1.29

Association of statin use and development and progression of hip osteoarthritis in elderly women. J Rheumatol (2005) 1.25

Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res (2004) 1.22

Patterns of compartment involvement in tibiofemoral osteoarthritis in men and women and in whites and African Americans. Arthritis Care Res (Hoboken) (2012) 1.20

Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. J Bone Miner Res (2010) 1.19

Relationship between joint shape and the development of osteoarthritis. Curr Opin Rheumatol (2010) 1.17

Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2009) 1.16

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Ann Rheum Dis (2009) 1.15

Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab (2009) 1.14

Lumbosacral transitional vertebrae: association with low back pain. Radiology (2012) 1.14

Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab (2010) 1.11

Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). J Clin Endocrinol Metab (2004) 1.09

IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J Immunol (2011) 1.08

Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study. J Am Geriatr Soc (2010) 1.07

Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells (2013) 1.06

Glucocorticoid dose determines osteocyte cell fate. FASEB J (2011) 1.06

Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis. Arthritis Rheum (2012) 1.05

Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women. Osteoporos Int (2004) 1.05

Role of bone architecture and anatomy in osteoarthritis. Bone (2012) 1.03

Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats. Osteoporos Int (2005) 1.02

Defining incident radiographic hip osteoarthritis for epidemiologic studies in women. Arthritis Rheum (2009) 1.02

The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength. Bone (2007) 1.02

To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol (2013) 1.01

Control of arthritis pain with anti-nerve-growth factor: risk and benefit. Curr Rheumatol Rep (2012) 0.99

The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat Rev Rheumatol (2012) 0.99

Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. J Bone Miner Res (2009) 0.98

Vanin-1 pantetheinase drives increased chondrogenic potential of mesenchymal precursors in ank/ank mice. Am J Pathol (2008) 0.98

Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. PLoS One (2007) 0.98

Kyphosis and decline in physical function over 15 years in older community-dwelling women: the Study of Osteoporotic Fractures. J Gerontol A Biol Sci Med Sci (2013) 0.98

Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nat Clin Pract Rheumatol (2008) 0.97

Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats. Bone (2009) 0.96

Consistency of knee pain and risk of knee replacement: the Multicenter Osteoarthritis Study. J Rheumatol (2011) 0.96

Osteoarthritis, bone mass, and fractures: how are they related? Arthritis Rheum (2002) 0.96

Femoroacetabular Impingement: Prevalent and Often Asymptomatic in Older Men: The Osteoporotic Fractures in Men Study. Clin Orthop Relat Res (2015) 0.92

Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Am J Med (2012) 0.92

Effects of inflammation on bone: an update. Curr Opin Rheumatol (2011) 0.92

Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice. PLoS One (2010) 0.92

Active shape modeling of the hip in the prediction of incident hip fracture. J Bone Miner Res (2011) 0.92

Association of incident symptomatic hip osteoarthritis with differences in hip shape by active shape modeling: the Johnston County Osteoarthritis Project. Arthritis Care Res (Hoboken) (2014) 0.90

Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). Osteoporos Int (2005) 0.89

Effect of glucocorticoids on bone density. Med Pediatr Oncol (2003) 0.89

Glucocorticoid-induced osteoporosis. Curr Osteoporos Rep (2009) 0.89

Self-reported weight at birth predicts measures of femoral size but not volumetric BMD in eldery men: MrOS. J Bone Miner Res (2011) 0.89

Kyphosis and paraspinal muscle composition in older men: a cross-sectional study for the Osteoporotic Fractures in Men (MrOS) research group. BMC Musculoskelet Disord (2014) 0.88

Medication-induced osteoporosis. Curr Osteoporos Rep (2007) 0.86

Radiographic methods in knee osteoarthritis: a further comparison of semiflexed (MTP), schuss-tunnel, and weight-bearing anteroposterior views for joint space narrowing and osteophytes. J Rheumatol (2002) 0.86

Hand joint space narrowing and osteophytes are associated with magnetic resonance imaging-defined knee cartilage thickness and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. J Rheumatol (2011) 0.85

Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization. Bone (2006) 0.85

Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients. Clin Transplant (2010) 0.85

Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically ill patients. Biomark Insights (2011) 0.84

Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents. J Bone Miner Res (2011) 0.84

High hip fracture risk in men with severe aortic calcification: MrOS study. J Bone Miner Res (2014) 0.82

Glucocorticoids and osteocyte autophagy. Bone (2013) 0.82

Targeting the Wnt signaling pathway to augment bone formation. Curr Osteoporos Rep (2008) 0.82

Are There Sex Differences in Knee Cartilage Composition and Walking Mechanics in Healthy and Osteoarthritis Populations? Clin Orthop Relat Res (2015) 0.82

Diffuse idiopathic skeletal hyperostosis association with thoracic spine kyphosis: a cross-sectional study for the Health Aging and Body Composition Study. Spine (Phila Pa 1976) (2014) 0.82

Frailty and hip osteoarthritis in men in the MrOS cohort. J Gerontol A Biol Sci Med Sci (2013) 0.81

Accuracy of self-reported diagnosis of hip replacement. Arthritis Care Res (Hoboken) (2010) 0.81

The management of secondary osteoporosis. Best Pract Res Clin Rheumatol (2005) 0.81

Femoroacetabular impingement. Arthritis Rheumatol (2015) 0.80

Common genetic variation in the Estrogen Receptor Beta (ESR2) gene and osteoarthritis: results of a meta-analysis. BMC Med Genet (2010) 0.79

Parathyroid hormone update. Rheum Dis Clin North Am (2006) 0.79

Common mistakes in the clinical use of bone mineral density testing. Nat Clin Pract Rheumatol (2008) 0.78

Actigraphy- and Polysomnography-Measured Sleep Disturbances, Inflammation, and Mortality Among Older Men. Psychosom Med (2016) 0.78

Improved trabecular bone structure of 20-month-old male spontaneously hypertensive rats. Calcif Tissue Int (2014) 0.77

Global point signature for shape analysis of carpal bones. Phys Med Biol (2014) 0.76

Hip pain while using lower extremity joints and sleep disturbances in elderly white women: results from a cross-sectional analysis. Arthritis Care Res (Hoboken) (2012) 0.75

β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes. Clin Orthop Relat Res (2015) 0.75

Osteoporosis: yesterday, today and tomorrow. Rheumatology (Oxford) (2011) 0.75

Editorial Comment: Symposium: Sex Differences in Musculoskeletal Disease and Science. Clin Orthop Relat Res (2015) 0.75

Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model. Bone (2012) 0.75